These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 324693)

  • 1. Influence of alprenolol on hemodynamic and metabolic responses to prolonged exercise in subjects with hypertension.
    Frisk-Holmberg M; Jorfeldt L; Juhlin-Dannfeldt A
    Clin Pharmacol Ther; 1977 Jun; 21(6):675-84. PubMed ID: 324693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of long-term anti-hypertensive beta-receptor-blocking treatment on haemodynamic and metabolic responses to prolonged exercise in man.
    Frisk-Holmberg M; Juhlin-Dannfeldt A; Jorfeldt L; Aström H
    Clin Sci Mol Med Suppl; 1976 Dec; 3():489s-491s. PubMed ID: 1071668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic changes in muscle on long-term alprenolol therapy.
    Frisk-Holmberg M; Jorfeldt L; Juhlin-Dannfelt A; Karlsson J
    Clin Pharmacol Ther; 1979 Nov; 26(5):566-71. PubMed ID: 498698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic changes at rest and during exercise in long-term beta-blocker therapy of essential hypertension.
    Lund-Johansen P
    Acta Med Scand; 1974; 195(1-2):117-21. PubMed ID: 4817079
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of alprenolol on hemodynamics in angina pectoris.
    Cullhed I
    Acta Med Scand; 1973 May; 193(5):411-8. PubMed ID: 4717322
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of alprenolol on central hemodynamics and exercise tolerance in patients with angina pectoris.
    Jonsson B; Olsson AG; Orö L
    Cardiology; 1973; 58(3):152-61. PubMed ID: 4149331
    [No Abstract]   [Full Text] [Related]  

  • 7. Alprenolol alone and in conjunction with pentanitrol in angina pectoris. A double-blind study with exercise tests.
    Hansen PF; Rasmussen PA; Nyberg G
    Acta Med Scand; 1973 May; 193(5):419-24. PubMed ID: 4197873
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of beta-adrenergic blockade with alprenolol on ST-segment depression and circulatory dynamics during exercise in patients with effort angina.
    Bailey IK; Anderson SD; Rozea PJ; Bernstein L; Nyberg G; Korner PI
    Am Heart J; 1976 Oct; 92(4):416-26. PubMed ID: 961582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central haemodynamic effects in man of intravenous d-alprenolol during rest and exercise.
    Ekelund LG; Melcher A; Orö L
    Eur J Clin Pharmacol; 1971 Sep; 3(4):198-203. PubMed ID: 5151303
    [No Abstract]   [Full Text] [Related]  

  • 10. Haemodynamic effects of saluretic treatment and beta-receptor blockade in patients with essential hypertension.
    Bevegård S; Castenfors J; Danielson M
    Acta Med Scand; 1977 Jan; 201(1-2):99-104. PubMed ID: 835380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cedilanid-D and alprenolol in angina pectoris.
    Ekelund LG; Johnsson G; Melcher A; Orö L
    Eur J Clin Pharmacol; 1973 Aug; 6(2):113-8. PubMed ID: 4769694
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of nisoldipine on systemic and leg blood flow, oxygen transport and metabolism, and hemodynamics during exercise in effort angina pectoris.
    Ram J; Freedman SB; Ogasawara S; Thomson A; Kelly DT
    Am J Cardiol; 1989 Apr; 63(12):802-6. PubMed ID: 2929436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic interference of alprenolol with dihydralazine in normal and hypertensive man.
    Sannerstedt R; Stenberg J; Johnsson G; Werkö L
    Am J Cardiol; 1971 Sep; 28(3):316-20. PubMed ID: 5155758
    [No Abstract]   [Full Text] [Related]  

  • 14. Haemodynamic long-term effects of metoprolol at rest and during exercise in essential hypertension.
    Lund-Johansen P; Ohm OJ
    Br J Clin Pharmacol; 1977 Apr; 4(2):147-51. PubMed ID: 861129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemodynamic long-term effects of beta-receptor-blocking agents in hypertension: a comparison between alprenolol, atenolol, metoprolol and timolol.
    Lund-Johansen P; Ohm OJ
    Clin Sci Mol Med Suppl; 1976 Dec; 3():481S-483S. PubMed ID: 15759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamic properties of beta-adrenergic receptor blocking drugs in man.
    Gibson DG
    Drugs; 1974; 7(1):8-38. PubMed ID: 4151693
    [No Abstract]   [Full Text] [Related]  

  • 17. Alprenolol and propranolol in the treatment of hypertension: a comparative study.
    Somer T; Luomanmäki K; Frick MH
    Acta Med Scand Suppl; 1974; 554():33-7. PubMed ID: 4593671
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute and long-term effects of nitrendipine on resting and exercise hemodynamics in essential hypertension.
    Nannan ME; Melin JA; Vanbutsele RJ; Lavenne F; Detry JM
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1043-8. PubMed ID: 6085364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic effects in muscle during antihypertensive therapy with beta 1- and beta 1/beta 2-adrenoceptor blockers.
    Frisk-Holmberg M; Jorfeldt L; Juhlin-Dannfelt A
    Clin Pharmacol Ther; 1981 Nov; 30(5):611-8. PubMed ID: 6117392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effect of alprenolol as antihypertensive agent.
    Bengtsson C
    Acta Med Scand Suppl; 1974; 554():9-14. PubMed ID: 4593676
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.